Key Takeaways On April 1, 2026, FDA issued a statement reminding 503A pharmacies and 503B outsourcing facilities that ...
The US Food and Drug Administration issued a warning Tuesday about compounded versions of the drug semaglutide, which is approved for treatment of diabetes and excess weight. Compounding “is the ...
Morning Overview on MSN
FDA weighs easing limits on compounded peptides amid wellness boom
Walk into almost any wellness clinic or anti-aging practice in the United States and you will find them: vials of compounded ...
Houston-based Empower Pharmacy is one of two compounding pharmacies sued by the pharmaceutical giant Eli Lilly earlier this month for allegedly selling "knockoff" versions of its weight loss and ...
Bagsværd, Denmark and Plainsboro, NJ, 5 February 2026 – Novo Nordisk today issued the following statement regarding the announcement by Hims & Hers that they will unlawfully mass-market an unapproved, ...
Novo Nordisk scored a huge legal victory that largely restricts compounding pharmacies from marketing or selling cheaper, unapproved versions of the drugmaker's blockbuster weight loss drug Wegovy and ...
Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant's weight loss drug Zepbound and its diabetes treatment Mounjaro, the company's latest attempt to ...
Add Yahoo as a preferred source to see more of our stories on Google. Patients have been buying compounded weight loss drugs at lower prices than brand-name medications amid shortages of tirzepatide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results